Please login to the form below

Not currently logged in
Email:
Password:

Europe delays EMA relocation decision

Will resolve the issue in November, one month later than expected

EMAThe decision on which country will host Europe’s pharma regulator once the UK leaves the European Union has been postponed by one month.

Currently based in London, the European Medicines Agency (EMA) is now expected to learn later this year in November where it will be moved to.

The decision will be taken at a meeting of the heads of state or government from the 27 states that will make up the EU after March 29, 2019, and its delay has prompted pharma to voice its concern.

European trade body EFPIA acknowledged the complexity of the Brexit negotiations, but argued in a statement “medicines constitute a special case in term of securing swift agreement on both sides”.

“It is imperative for the safeguarding of public health that we ensure future alignment between the UK and EU regulatory regimes in order to maintain capacity, processes and timeframes for the introduction of new medicines for patients,” it added.

Echoing this Dr Virginia Acha, executive director of research, medicine and innovation at the UK’s ABPI, said: “It will be critical to avoid divergence and duplication of regulatory regimes, so that patient safety is not put at risk."

The EU’s November meeting will also see the post-Brexit location decided of the European Banking Authority (EBA), which must leave London too.

EU member states can bid to host both, but - with the EMA’s fate to be decided first - the country that wins the right to the medicines regulator cannot then continue with its bid for the EBA.

Countries that have so far thrown their hats into the ring for the EMA contest include Copenhagen, Barcelona, Lisbon and Dublin - any more that are interested have until July 31 to submit their offer.

Article by
Dominic Tyer

26th June 2017

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics